Effect of the endothelin receptor antagonist CPU0213, and its modulation by rifampin, on cardiac and vascular tissue following chronic isoproterenol treatment

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 7, 2008, Pages 757-765

  Luo, Lu ^a   Dai, De Zai ^a   Dai, Yin ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

Cardiac hypertrophy; Drug enzyme induction; ETA receptor; FKBP12.6; Isoproterenol; Rifampin; Sarcoplasmic endoplasmic reticulum calcium ATPase (SERCA2a)

Indexed keywords

CPU 0213; ENDOTHELIN A RECEPTOR; ENDOTHELIN RECEPTOR ANTAGONIST; ISOPRENALINE; RIFAMPICIN; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INHIBITION; FEMALE; HEART HYPERTROPHY; HEMODYNAMICS; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE DRUG DOSE; WESTERN BLOTTING;

ANIMALS; AORTA, THORACIC; FEMALE; HEART; ISOPROTERENOL; MALE; MYOCARDIUM; PYRAZOLES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ENDOTHELIN; RIFAMPIN;

EID: 44249125543     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04856.x     Document Type: Article

References (28)

1. Osadchii OE, Woodiwiss AJ, Deftereos D et al. Temporal changes in myocardial adrenergic regulation with the progression to pump dysfunction after chronic beta-adrenoreceptor activation in rats. Pflügers Arch. 2007 455 : 251 60.
2. Ellison GM, Torella D, Karakikes I et al. Acute beta-adrenergic overload produces myocyte damage through calcium leakage from the ryanodine receptor 2 but spares cardiac stem cells. J. Biol. Chem. 2007 282 : 11 397 409.
3. Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: A new therapeutic target? Circulation. 2004 109 : 1580 9.
4. Wehrens XH, Lehnart SE, Huang F et al. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 2003 113 : 829 40.
5. Kedzierski RM, Yanagisawa M. Endothelin system. The doubled-edged sword in health and disease. Annu. Rev. Pharmacol. Toxicol. 2001 41 : 851 76.
6. Backs J, Bresch E, Lutz M, Kristen AV, Haass M. Endothelin-1 inhibits the neuronal norepinephrine transporter in hearts of male rats. Cardiovasc. Res. 2005 67 : 283 90.
7. Ramzy D, Rao V, Tumiati LC et al. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 2006 114 : I319 26.
8. Wehrens XH, Marks AR. Molecular determinants of altered contractility in heart failure. Ann. Med. 2004 36 : 70 80.
9. Guan L, Feng Y, Ji M et al. Pharmacokinetics of CPU0213, a novel endothelin receptor antagonist, after intravenous administration in mice. Acta Pharmacol. Sin. 2006 27 : 367 71.
10. Qi MY, Xia HJ, Dai DZ, Dai Y. A novel endothelin receptor antagonist CPU0213 improves diabetic cardiac insufficiency attributed to up-regulation of the expression of FKBP12.6, SERCA2a, PLB in rats. J. Cardiovasc. Pharmacol. 2006 47 : 729 35.
11. Yang TT, Dai DZ. Metabolic kinetics of CPU0213, an inhibitor of endothelin receptors, in rat liver microsomes. Asian J. Pharm. Sci. 2006 1 : 199 204.
12. Mahatthanatrakul W, Nontaput T, Ridtitid W et al. Rifampin, a cytochrome P450, 3A inducer, decreases plasma concentrations of antipsychotic risperidone in healthy volunteers. J. Clin. Pharm. Ther. 2007 : 32 : 161 7.
13. Yuan SH, Dai DZ, Guan L et al. CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro. Clin. Exp. Pharmacol. Physiol. 2006 33 : 1066 72.
14. Ding SS, Qiu C, Hess P, Xi JF, Clozel JP, Clozel M. Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failure. Cardiovasc. Res. 2002 53 : 963 70.
15. Griendling KK, FitzGerald GA. Oxidative stress and cardiovascular injury: Part I. Basic mechanisms and in vivo monitoring of ROS. Circulation 2003 108 : 1912 16.
16. B receptor, NADPH oxidase and caveolin-1. Br. J. Pharmacol. 2005 145 : 323 33.
17. Xu FP, Chen MS, Wang YZ et al. Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 2004 110 : 1269 75.
18. Marasciulo FL, Montagnani M, Potenza MA. Endothelin-1: The yin and yang on vascular function. Curr. Med. Chem. 2006 13 : 1655 65.
19. Lehnart SE, Terrenoire C, Reiken S et al. Stabilization of cardiac ryanodine receptor prevents intracellular calcium leak and arrhythmias. Proc. Natl Acad. Sci. USA 2006 103 : 7906 10.
20. Huang ZJ, Dai DZ, Li N et al. Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits. Clin. Exp. Pharmacol. Physiol. 2007 34 : 310 17.
21. He HB, Yu F, Dai DZ et al. Down-regulation of FKBP12.6 and SERCA2a contributes to acute heart failure in septic shock and is related to an up-regulated endothelin signalling pathway. J. Pharm. Pharmacol. 2007 59 : 977 84.
22. Feng Y, Dai DZ, Na T et al. Endothelin receptor antagonist CPU0213 suppresses ventricular fibrillation in l-thyroxin induced cardiomyopathy. Pharmacol. Rep. 2007 59 : 306 14.
23. Baltogiannis GG, Tsalikakis DG, Mitsi AC et al. Endothelin receptor-A blockade decreases ventricular arrhythmias after myocardial infarction in rats. Cardiovasc. Res. 2005 67 : 647 54.
24. Isaka M, Kudo A, Imamura M et al. Endothelin receptors, localized in sympathetic nerve terminals of the heart, modulate norepinephrine release and reperfusion arrhythmias. Basic Res. Cardiol. 2007 102 : 154 62.
25. Na T, Huang ZJ, Dai DZ et al. Abrupt changes in FKBP12.6 and SERCA2a expression contribute to sudden occurrence of ventricular fibrillation on reperfusion and are prevented by CPU86017. Acta Pharmacol. Sin. 2007 28 : 773 82.
26. Wang HL, Dai DZ, Gao E et al. Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats. Acta Pharmacol. Sin. 2004 25 : 738 43.
27. Bolt HM. Rifampicin, a keystone inducer of drug metabolism: From Herbert Remmer's pioneering ideas to modern concepts. Drug Metab. Rev. 2004 36 : 497 509.
28. Feng Y, Dai DZ, Tang XY et al. Reversal of isoproterenol induced downregulation of phospholamban is mediated by antagonism of endothelin receptors of CPU0213. Acta Pharmacol. Sin. 2007 28 : 1746 54.